Using advanced AI-driven protein design, researchers have successfully modified parts of the ribosome to operate without one of the 20 canonical amino acids, isoleucine, demonstrating that early life forms might have relied on a simplified genetic code.

  • Engineered ribosome proteins to use 19 amino acids, removing isoleucine
  • AI-driven design aided substitution and optimization of protein sequences
  • Study supports theories of simpler ancestral genetic codes

What happened

A collaborative team of scientists from Columbia and Harvard set out to test the hypothesis that early life may have used fewer than 20 amino acids in its genetic code. They focused on isoleucine, one of three similar hydrophobic amino acids, due to its frequent substitution in related bacterial species. Starting with a subset of essential genes in E. coli, the researchers replaced isoleucine residues with valine, observing which proteins and cellular functions tolerated the change.

Focusing on the ribosome—the molecular machine responsible for protein synthesis—they applied AI-based protein design to redesign 32 genes encoding ribosomal proteins that showed reduced fitness when isoleucine was swapped out. This approach allowed them to create functional ribosomes operating without isoleucine, although cellular growth rates were often slower compared to unedited cells.

Advertising
Reserved for inline-leaderboard

Why it matters

The universal use of 20 amino acids in the genetic code is a foundational pillar of molecular biology, and understanding whether this number can be altered sheds light on how life’s complexity evolved. Demonstrating that ribosomes can function with only 19 amino acids challenges the assumption that all 20 are strictly essential and supports theories that primordial life forms used a simpler set before the establishment of the modern genetic code.

Moreover, the study highlights the power of AI-driven protein engineering to explore biology’s fundamental constraints. This technology enables researchers to undertake ambitious rewiring of cellular machinery that would have been infeasible previously, opening new avenues for synthetic biology and evolutionary studies.

What to watch next

Future research will likely extend this approach to other amino acids and more comprehensive gene sets, testing the limits of genetic code simplification across different organisms. Scientists will also investigate whether cells can recover normal growth rates with further optimizations or compensatory mutations.

Additionally, the integration of AI tools in protein design is expected to accelerate efforts to both simplify and expand the genetic code, potentially enabling organisms with novel biochemical properties and advancing applications in biotechnology, medicine, and understanding life’s origins.

Source assisted: This briefing began from a discovered source item from Ars Technica. Open the original source.
How SignalDesk reports: feeds and outside sources are used for discovery. Public briefings are edited to add context, buyer relevance and attribution before they are published. Read the standards

Related briefings